Dan Yan | Pharmacology | Best Researcher Award

Dan Yan | Pharmacology | Best Researcher Award

Prof. Dan Yan, Beijing Friendship Hospital, Capital Medical University, China China

Prof. Dan Yan is the Director of the Pharmacy Department and Vice Director of the Drug Clinical Trial Institution at Beijing Friendship Hospital, Capital Medical University. A leading expert in intelligent molecular diagnosis and combination therapies for chronic metabolic diseases, he has authored numerous high-impact publications and led national research projects. With a Ph.D. from Chengdu University of Traditional Chinese Medicine and postdoctoral training in cell biology, Prof. Yan also serves on key national academic committees. He work bridges traditional Chinese medicine with modern pharmacology to advance precision healthcare.

Publication Profile

Scopus

Education

Prof. Dan Yan 🎓 has dedicated he academic journey to the field of Traditional Chinese Medicine. He earned he Ph.D. (2004–2007), M.S. (2001–2004), and B.S. (1994–1998) degrees—all from the esteemed Chengdu University of Traditional Chinese Medicine 🏛️. He consistent pursuit of knowledge over the years reflects a deep passion for advancing holistic health and medical science rooted in ancient wisdom 🌿. With a strong foundation in both theoretical and practical aspects of Traditional Chinese Medicine, Prof. Yan continues to contribute significantly to research, education, and innovation in this timeless and evolving discipline 📚🔬.

Experience

Prof. Dan Yan 🌟 has actively served on numerous prestigious academic committees, showcasing he leadership in Traditional Chinese Medicine. Since 2023, he has been recognized as a National High-level Leading Talent 🇨🇳, Director of a Key Discipline under the National Administration of TCM 🏛️, and a recipient of the Chinese Government Special Allowance 🏅. He is also a member of the China National Pharmacopoeia Committee (2022–2027) 📘 and holds leadership roles in institutes focused on clinical pharmacy, precision medicine, and rational drug use 💊📊. He extensive contributions highlight he dedication to advancing science, policy, and international collaboration in healthcare 🌐🧬.

Research Focus

Prof. Dan Yan is a leading researcher in metabolic diseases, particularly focusing on type 2 diabetes, insulin resistance, and gut microbiota 🧫. He research integrates microbiome science, metabolomics, and traditional Chinese medicine🌿 to develop novel therapeutic strategies. He investigates microbial metabolites (e.g., succinate, L-citrulline) and their roles in modulating intestinal immunity🦠 and enhancing drug responses like metformin efficacy💊. He studies also include chemodynamic therapy, biomarker discovery, and machine learning-based screening in diabetes diagnostics 🤖. Prof. Yan’s contributions are reshaping how we understand and manage chronic metabolic disorders on a molecular and systemic level.

Publication Top Notes

Lactobacillus murinus alleviates insulin resistance via promoting L-citrulline synthesis

Function, mechanism of action, metabolism, and commercial application of Lonicera japonica: a review

Coupling Probiotics with CaO2 Nanoparticle-Loaded CoFeCe-LDH Nanosheets to Remodel the Tumor Microenvironment for Precise Chemodynamic Therapy

Microbial succinate promotes the response to metformin by upregulating secretory immunoglobulin a in intestinal immunity

Circulating metabolites difference in type 2 diabetes patients from regions: a cross-sectional study

Detecting key genes relative expression orderings as biomarkers for machine learning-based intelligent screening and analysis of type 2 diabetes mellitus

Advances in in vitro assessment models and screening methods for blood glucose-lowering medications

Discovery of the targets and lead compounds of traditional chinese medicine based on the molecular trajectory of diabetes evolution

3D spheroid HepaRG and fluorescent biphasic tracer for CYP3A4-mediated antibiotic interaction monitoring in sepsis

Integrated biomarker profiling for predicting the response of type 2 diabetes to metformin

Sabine Asmus | Pharmacodynamics | Best Researcher Award

Sabine Asmus | Pharmacodynamics | Best Researcher Award

Prof. Dr. Sabine Asmus, Sorabistik Leipzig, Germany

Born in Berlin, Prof. Dr. Sabine Asmus is a distinguished linguist specializing in Celtic, English, and Slavic languages. She earned her PhD in translation studies from Humboldt University and has lectured in Germany, Austria, Poland, and beyond. She founded Poland’s first Celtic Department and the journal Res Celticae. A prolific researcher in lexicology and language revitalization, she has worked extensively in Wales and now contributes to the Sorbian Department at Leipzig University. A frequent media contributor, she continues to bridge linguistic and cultural gaps through research, teaching, and translation. 🎓

Publication Profile

orcid

Academic Excellence

Prof. Dr. Sabine Asmus is a distinguished scholar in linguistics, specializing in Celtic and English Studies. 📚 Her academic journey began with a PhD in translation studies from Humboldt-University Berlin, showcasing her dedication to research and education. 🌍 With a career spanning Germany, Wales, Austria, Poland, and France, she has made a global impact in language studies. 🏛️ Her work reflects a deep commitment to linguistic research, cultural preservation, and knowledge dissemination. ✍️ Through her extensive contributions, Prof. Dr. Asmus continues to shape the field of linguistics, inspiring scholars and students worldwide.

Experience 

Prof. Dr. Sabine Asmus is a trailblazer in linguistics, renowned for establishing the first Celtic Department in Poland and the Department of Celtic Languages and Cultures at Szczecin University. 🎓 Her pioneering work in lexicology, lexicography, and language revitalization, especially with the Sorbian languages, showcases her innovative approach to research. 📖🔍 Beyond academia, she actively contributes to media and public discourse, making complex linguistic topics accessible to wider audiences. 🎙️🗣️ Her dedication to preserving and promoting endangered languages underscores her impact in the field, inspiring scholars and language enthusiasts worldwide. 🌍✨

Academic Leadership

Prof. Dr. Sabine Asmus is a dedicated academic leader, mentoring numerous BA, MA, and PhD scholars with a passion for fostering research excellence. 🎓📚 Her commitment to linguistic diversity and student development highlights her profound impact on the academic community. 🌍✍️ Beyond the classroom, she actively engages with the public through media contributions, promoting language preservation and awareness. 🎙️🗣️ Her influence in academia and beyond makes her a strong candidate for the Best Researcher Award, recognizing her outstanding contributions to linguistic studies and education. 🏆

Research Focus

Prof. Dr. Sabine Asmus is a distinguished linguist specializing in Celtic languages, particularly Welsh and Irish 🏛️📜. Her research encompasses phonetics, phonology, syntax, and semantic evolution 🗣️🔤. She has extensively studied Welsh verbal nouns, aspectuality, consonant mutations, and vowel length, alongside comparative linguistic studies between Celtic and Slavic languages 🌍📖. She also explores language planning and revitalization strategies, with a keen interest in color semantics in Welsh and Irish 🎨📝. Her work includes books, journal articles, and conference papers, making significant contributions to linguistics, phonetics, and language education 📚🏅.

Publication Top Notes

Yuzhu Cai | Pharmacology | Best Researcher Award

Yuzhu Cai | Pharmacology | Best Researcher Award

Dr. Yuzhu Cai, Beihang University, China

Dr. Yuzhu Cai is a dedicated researcher in software engineering, currently pursuing a Ph.D. at Beihang University, China. He earned his Bachelor’s degree in Information Security with a Mathematics minor from Nankai University. An award-winning innovator, he has secured top honors in national competitions, including cryptography, algorithm design, and mathematical modeling. His research spans AI ethics, cybersecurity, and password security, with notable publications in Cell Patterns and ICLR 2025. Co-founder of Han Hai Xing Tu Technology, he pioneers AI-driven educational platforms. His contributions in cryptography and AI showcase his passion for innovation and security. ✨📊

Publication Profile

Education

Dr. Yuzhu Cai 🎓 is a dedicated scholar in the field of software engineering. He is currently pursuing his Ph.D. in Software Engineering at Beihang University, Tianjin, China (Sept 2024 – Present) 🖥️. Prior to this, he earned his Bachelor of Science in Information Security from Nankai University (Sept 2020 – Jul 2024) 🔐. Alongside his major, he also pursued a Minor in Mathematics (Sept 2021 – June 2023) ➗, further strengthening his analytical skills. With a strong academic foundation and a passion for innovation, Dr. Cai continues to advance in the field of technology and cybersecurity.

Awards

Dr. Yuzhu Cai 🎖️ has received numerous prestigious awards for his excellence in information security, cryptography, and mathematics. He secured First Prize in the National Information Works Competition 🏆, along with the Most Innovative and Entrepreneurial Value Award. He also won First Prize in the 7th National Cryptography Technology Competition 🔐 and the National College Students’ Mathematical Modeling Competition (Tianjin Area) 📊. His achievements include a Bronze Medal in the National Algorithm Design and Programming Challenge 💻 and First Prize in the Tianjin Electronic Design Competition. Additionally, he earned multiple scholarships 🏅, including Nankai University’s Public Ability and Innovation Scholarships. 🚀

Scientific Contributions

Dr. Yuzhu Cai 🧑‍🔬 has made remarkable contributions to the field of artificial intelligence and cybersecurity. He has co-authored influential publications in top-tier journals like Cell Patterns 📄 and presented groundbreaking research at ICLR 2025 🤖, focusing on AI ethics and multi-agent collaboration networks. His ongoing studies delve into password security 🔐, large language models (LLMs) 🧠, and AI-driven educational platforms 🎓, showcasing his dedication to cutting-edge innovation. With a strong research portfolio and a passion for technological advancements, Dr. Cai continues to shape the future of AI and cybersecurity. 🚀

Industry

Beyond academic research, Dr. Yuzhu Cai 🌟 has played a key role in applied technology projects, bridging the gap between innovation and real-world solutions. He contributed to HoneyCloud ☁️🔐, a secure multi-cloud password manager, enhancing cybersecurity practices. Additionally, he was involved in Han Hai Xing Tu 🎓🤖, an AI-driven educational planning platform, revolutionizing personalized learning. His entrepreneurial mindset 💡 and collaborative research efforts strengthen his influence across both academia and industry. With a passion for technological advancement and practical solutions, Dr. Cai continues to drive impactful innovations in AI, security, and education.

Research Focus

Dr. Yuzhu Cai’s research focuses on ensuring the ethical use of AI, particularly in aligning open-source text-to-image models with societal values. In the paper “Ethical-Lens: Curbing Malicious Usages of Open-Source Text-to-Image Models,” Dr. Cai and colleagues introduce Ethical-Lens, a framework designed to prevent the generation of harmful or biased content by these models. This framework operates without altering the internal structures of existing models, instead refining user inputs and adjusting outputs to adhere to ethical standards. By addressing issues like toxicity and bias, Ethical-Lens aims to promote the responsible development and integration of AI tools into society.

Tang Jin-Bao | Pharmacology | Best Researcher Award

Tang Jin-Bao | Pharmacology | Best Researcher Award

Prof. Dr Tang Jin-Bao,Shandong Second Medical University,China

Prof. Dr. Jin-Bao Tang, a licensed pharmacist in China, is a professor at Shandong Second Medical University. He earned his Ph.D. in Microbial and Biochemical Pharmacy from Shandong University in 2023. An esteemed graduate sponsor in Shandong Province, he specializes in Biotechnological Pharmaceutics and Pharmaceutical Engineering. His research focuses on developing novel immunoassay biosensors for proteins and peptides. With multiple high-impact publications in Food Chemistry and Analytical Bioanalytical Chemistry, he has pioneered advanced immunosensor technologies. His innovative contributions to biosensor development enhance precision in food safety and biomedical analysis. 🔬📚

Publication Profile

Scopus

Education

Prof. Dr. Jin-Bao Tang 🎓 holds a Doctorate in Microbial and Biochemical Pharmacy from Shandong University (2023) and is a licensed pharmacist in China. As a distinguished professor at Shandong Second Medical University, he plays a vital role in educating future pharmaceutical professionals in Biotechnological Pharmaceutics and Pharmaceutics Engineering 🧪. His dedication to academia is evident through his mentorship and contributions to pharmaceutical sciences. Recognized as an excellent graduate sponsor of Shandong Province 🏆, Dr. Tang’s expertise and commitment continue to shape the next generation of researchers and industry leaders in the field of pharmacy. 💊

Scientific Community

Prof. Dr. Jin-Bao Tang 🧑‍🔬 has made a significant impact in the scientific community through his groundbreaking research in biotechnology and pharmacology. His publications appear in prestigious journals such as Food Chemistry, International Journal of Biological Macromolecules, Food Control, and Analytical Bioanalytical Chemistry 📚. His collaborative work has led to advancements in oriented antibody immobilization, photoconjugation strategies, and biosensor technology 🧪, with profound implications for public health, biotechnology, and pharmacological applications. Through his innovative contributions, Prof. Tang continues to shape the future of pharmaceutical sciences, enhancing diagnostic and therapeutic approaches for global healthcare. 🌍💊

Research Contributions

Prof. Dr. Tang Jin-Bao’s research revolves around developing novel immunoassay biosensors for protein and peptide detection 🧪🔬. His pioneering work has significantly advanced biosensing technology, particularly in food safety and biomedical analysis 🍎⚕️. Over the past five years, his high-impact publications have introduced innovative techniques such as electrochemical immunosensors for aflatoxin detection ⚡, bioluminescent immunoassays using antibody-nanoluciferase conjugates ✨, and Fc-specific antibody modifications for enhanced biosensor performance 🧫. Additionally, his photoconjugation strategies have led to stable fluorescent antibody fabrication 🌟. These breakthroughs contribute immensely to food safety, pharmaceutical analysis, and immunodiagnostics, demonstrating the real-world impact of his research. 🚀

Research Focus

Prof. Dr. Jin-Bao Tang’s research primarily focuses on biosensors 🧪, immunoassays 🏥, and antibody engineering 🧬 for food safety and biomedical applications. His work involves developing electrochemical immunosensors ⚡, bioluminescent assays 💡, and advanced antibody modifications 🏗️ to enhance the detection of harmful contaminants like aflatoxin B1 🍄⚠️. He explores oriented antibody immobilization 🎯 to improve sensitivity and specificity in bioanalytical methods. Additionally, his research extends to drug delivery systems 💊, particularly in pulsatile release formulations ⏳, using innovative polymers. His contributions advance food safety 🥗, biomedical diagnostics 🏥, and pharmaceutical technologies 💊 for global health and safety.

Publication Top Notes

A facile and effective electrochemical immunosensor based on controlled and oriented immobilization of natural antibodies for sensitive detection of aflatoxin B1

Development of a bioluminescent immunoassay based on Fc-specific conjugated antibody–nanoluciferase immunoreagents for determining aflatoxin B1

Fabrication of cysteine-modified antibodies with Fc-specific conjugation for covalent and oriented immobilization of native antibodies

Preparation of enteric capsules with pulsatile drug delivery potential using pullulan and polyacrylic acid resin III

Dr. Rahul Reddy|Pharmacology|Excellence in Research

Dr.RahulReddy|Pharmacology|Excellence in Research

Dr. Rahul Reddy at Lautoka Hospital ,Fiji

PROFILE  

Google scholar

Early Academic Pursuits 🎓

Rahul Krishna Reddy, a passionate medical professional, laid the foundation of his academic journey at Lautoka Andhra Sangam Primary School, where he studied from 2000 to 2008. He then progressed to Natabua High School (2009–2013), excelling academically and developing a keen interest in the medical sciences. His educational journey gained international momentum when he pursued a Chinese language program (HSK Level 4) at Shandong University in 2013–2014. This preparatory phase was instrumental in equipping him with linguistic skills for his future studies in China.

Rahul enrolled at Dalian Medical University (2014–2019), where he earned his MBBS degree. His time at Dalian was marked by rigorous academic training and multiple internships, including at the First Affiliated Hospital of Dalian Medical University. This exposure to advanced medical systems honed his clinical skills and solidified his career in surgery and medicine.

Professional Endeavors 🩺

Rahul’s professional journey is a testament to his dedication and commitment to the healthcare field. His initial post-MBBS years were spent at renowned institutions, including the Colonial War Memorial Hospital and Lautoka Hospital, where he completed intensive internship programs (2019–2021). These internships provided him with hands-on experience in diverse medical and surgical disciplines.

From 2021 to 2022, he played a crucial role in Fiji’s fight against COVID-19 as part of the Nadroga/Navosa COVID Team, showcasing his adaptability and resilience in public health crises. Later, as a Medical Officer at Vatukarasa Health Center (2022–2023), Rahul delivered primary care services, demonstrating his ability to cater to the diverse medical needs of his community. Currently, he serves as a Surgical Registrar at Lautoka Hospital, focusing on complex surgical cases and contributing significantly to patient outcomes.

Contributions and Research Focus 🔬

Rahul has made significant strides in clinical research, focusing on improving healthcare outcomes in Fiji. His studies have explored critical areas such as burn injuries, appendicitis, and innovative surgical techniques. Notable publications include:

  • Burns Injury Characteristics and Outcomes at Lautoka Hospital, highlighting critical insights into managing burn patients in resource-limited settings.
  • Research on acute appendicitis outcomes, offering data-driven recommendations for improving surgical care in Fiji.
  • Pioneering work on laparoscopic radical prostatectomy, reflecting his interest in minimally invasive surgery.
  • Contributions to the understanding of rare cases like primary epithelioid hemangioendothelioma and seminal vesicle cystadenoma through internationally recognized publications.

Rahul’s commitment to research and evidence-based practice demonstrates his dedication to advancing medical science in the Pacific region.

Accolades and Recognition 🏆

Rahul’s work has been recognized both nationally and internationally. In 2024, he won the Outstanding Young Investigator Award at the Fiji Medical Association Research Conference. His impactful presentations at conferences, including the Diabetic Foot Symposium and the Pacific Islands Health Research Symposium, have established him as a thought leader in surgical and public health topics.

Rahul has also actively participated in workshops, such as the EMSB and Pain Management sessions, further enhancing his clinical expertise. His continued professional development reflects his commitment to lifelong learning.

Impact and Influence 🌏

Rahul’s influence extends beyond the operating room. As a healthcare provider in Fiji, he has been instrumental in improving patient care and mentoring junior medical staff. His research contributions address key regional healthcare challenges, ensuring evidence-based practices are integrated into daily medical routines.

During the COVID-19 pandemic, his involvement in the Nadroga/Navosa COVID Team was pivotal in managing the outbreak, reflecting his leadership skills and community dedication.

Legacy and Future Contributions 🚀

Rahul Krishna Reddy is poised to leave a lasting legacy in the medical field. His combination of clinical expertise, research acumen, and community service positions him as a trailblazer in Fijian healthcare. Looking ahead, Rahul envisions expanding his contributions to global medical research, particularly in surgical innovation and healthcare systems in resource-limited settings.

His unwavering dedication to improving healthcare outcomes and fostering medical education ensures his enduring impact. As he continues to grow professionally, Rahul exemplifies the values of compassion, innovation, and excellence in medicine.

Conclusion 🌟

From his early academic achievements to his current role as a Surgical Registrar, Rahul Krishna Reddy’s journey reflects an unwavering commitment to healthcare. His research and clinical endeavors are paving the way for improved medical practices in Fiji and beyond. Rahul’s accomplishments and aspirations set a high standard for the next generation of medical professionals, cementing his position as a leader in the field.

🎓Publication 

Laparoscopic excision of seminal vesicle cystadenoma

  • Authors   : Qi Zhen Tang, Zhong Lin, Rahul Krishna Reddy, Zhi Wei Zhang
  • Journal    : Urology Case Reports
  • Year         :2019

Burns injury characteristics and outcomes at lautoka hospital, fiji

      • Authors   : Rahul Krishna Reddy, Arun Murari, Akhtar Ali, Ronal Kumar, Livai Lutunaika, Abhay Choudhari, Swastika Devi, Famiza Kulsum
      • Journal    : Burns Open
      • Year         :2024

Characteristics and Outcomes of Acute Appendicitis in Lautoka Aspen Hospital, Fiji: An Observational Retrospective Study

  • Authors   : Rahul Krishna Reddy, M Arun, K Ronal, Akhtar Ali, Livai Lutunaika, Y Devi Chandra
  • Journal    : World J Surg Surgical Res
  • Year         :2024

Primary Epithelioid Hemangioendothelioma of the Kidney Pelvis

  • Authors   :Rahul Reddy
  • Journal     : American Journal of Surgery and Clinical Case Reports
  • Year         :2020                                                                                                                                                                                                                                                 

Prof Dr. Ronit Sverdlov|Pharmacology|Best Researcher Award

Prof Dr. Ronit Sverdlov|Pharmacology|Best Researcher Award

Prof Dr. Ronit Sverdlov at Maastricht University,Netherlands

PROFILE  

ORCID

Scopus

 

Early Academic Pursuits 🎓

Dr. Ronit Shiri-Sverdlov’s academic journey began with a Master’s degree in Biochemistry and Cellular Biology from Tel-Aviv University in Israel, where she graduated magna cum laude. This period was instrumental in shaping her deep interest in cellular and molecular mechanisms, a theme that would remain central to her later work. Building on her foundational knowledge, she pursued a Ph.D. in Molecular Genetics at Tel-Aviv University’s Sheba Medical Center, under the supervision of Prof. E. Friedman. Her doctoral research, focused on identifying germline mutations in the BRCA1 and BRCA2 genes among high-risk Jewish and Arab populations, underscored her commitment to precision genetics and earned her a magna cum laude distinction upon graduation in 2002.

Professional Endeavors 💼

Dr. Shiri-Sverdlov joined Maastricht University’s Department of Molecular Genetics in 2001 as a postdoctoral researcher, working with Prof. M.H. Hofker. Her early postdoctoral work provided the groundwork for her lifelong focus on metabolic health, hepatic inflammation, and cholesterol metabolism. In 2004, she transitioned into a faculty position, first as an Assistant Professor and later, an Associate Professor by 2012. In 2016, she was appointed a Full Professor of Hepatic Inflammation and Metabolic Health, reflecting her leadership and expertise in the field. Dr. Shiri-Sverdlov currently leads a vibrant research team within the Faculty of Health, Medicine, and Life Sciences at Maastricht University, where she oversees projects focusing on liver disease, metabolic health, and inflammation under the NUTRIM School of Nutrition and Translational Research in Metabolism.

Contributions and Research Focus 🔬

Dr. Shiri-Sverdlov’s research centers on understanding and combating liver-related diseases, particularly non-alcoholic steatohepatitis (NASH), through molecular insights into cholesterol trafficking and hepatic inflammation. Her investigations have brought critical attention to lysosomal dysfunction as a biomarker for early NASH detection. This research has garnered substantial support, including a €1 million TKI grant in 2017 and several large fellowships from the Dutch Digestive Foundation and NWO ZonMw. Her work emphasizes the role of cholesterol metabolism in Kupffer cells (liver macrophages) and its impact on inflammatory pathways—a field where her studies continue to yield promising therapeutic insights.

Accolades and Recognition 🏆

Over the years, Dr. Shiri-Sverdlov has earned numerous prestigious awards. Her early career was marked by the VENI, VIDI, and ASPASIA fellowships from NWO ZonMw, which collectively supported her pioneering work in cholesterol metabolism and liver inflammation. She received the Marie Sklodowska-Curie Seal of Excellence in 2018, reflecting her proposal’s high evaluation score. She was also awarded the Education Prize by Maastricht University in 2018 for her leadership in developing the Biomedical Sciences curriculum. Additionally, she has been nominated for multiple awards, reflecting her influence in both research and teaching.

Impact and Influence 🌐

Dr. Shiri-Sverdlov has made a significant impact in the field of hepatic health through her research and mentorship. Her work on hepatic lysosomal biomarkers has been pivotal in early disease detection for NASH, with implications for both clinical practice and drug development. As a member of key grant committees, including the Netherlands Organization for Scientific Research (NWO) and the Novo Nordisk Foundation, she actively shapes the research landscape. Her collaboration with researchers across Europe, including those at the University of Reading and Strasbourg University, has contributed to a robust network of shared knowledge and advances in metabolic health.

Legacy and Future Contributions 🌱

Looking to the future, Dr. Shiri-Sverdlov is committed to advancing the understanding of liver diseases through cutting-edge research. Her work not only contributes to therapeutic advancements in NASH and hepatic inflammation but also inspires the next generation of scientists. Through her teaching roles, she continues to influence and guide students in Biomedical Sciences and Nutrition, instilling in them a commitment to rigorous research. Her legacy is further enriched by her leadership in scientific societies, where she champions innovative approaches to metabolic and hepatic health research.

🎓Publication 

Plasma cathepsin D as an early indicator of alcohol-related liver disease

  • Authors   :Li, M., Houben, T., Bitorina, A.V., Thiele, M., Shiri-Sverdlov, R.
    JHEP Reports,
  • Year         :2024

The Modulatory Effects of Fatty Acids on Cancer Progression

  • Authors   :Westheim, A.J.F., Stoffels, L.M., Dubois, L.J., Shiri-Sverdlov, R., Theys, J.
  • Journal    : Biomedicines
  • Year         :2023

All Roads Lead to Cathepsins: The Role of Cathepsins in Non-Alcoholic Steatohepatitis-Induced Hepatocellular Carcinoma

  • Authors   :van Mourik, H., Li, M., Baumgartner, S., Theys, J., Shiri-Sverdlov, R.
  • Journal    :Biomedicines
  • Year         :2022

Fatty Acids as a Tool to Boost Cancer Immunotherapy Efficacy

  • Authors   : Westheim, A.J.F., Stoffels, L.M., Dubois, L.J., Shiri-Sverdlov, R., Theys, J.
  • Journal    : Frontiers in Nutrition
  • Year         :2022

Serum CathepsinD in pregnancy: Relation with metabolic and inflammatory markers and effects of fish oils and probiotics

  • Authors   : Mokkala, K., Gustafsson, J., Vahlberg, T., Plat, J., Laitinen, K.
  • Journal    :Nutrition, Metabolism and Cardiovascular Diseases
  • Year         :2022

Prof. Anca Oana Hermenean |Pharmacology |Best Innovation Award

Prof. Anca Oana Hermenean|Pharmacology |Best Innovation Award|

Prof. Anca Oana Hermenean at Vasile Goldis Western University of Arad, Romania

PROFILE  

scopus

Orcid

Early Academic Pursuits 📚

Prof. Dr. Anca Hermenean began her academic journey at Babes-Bolyai University of Cluj-Napoca, Romania, where she earned her Bachelor’s degree in Biology from 1989 to 1994. This foundational education set the stage for her extensive career in biochemistry and molecular biology. Her academic prowess continued to shine as she pursued a PhD in Biology from 1997 to 2003, focusing on electron microscopy, histopathology, and immunohistochemistry. This period of intense study was marked by rigorous research and a commitment to understanding the microscopic and molecular mechanisms underlying various biological processes.

Professional Endeavors 🏛️

Prof. Hermenean’s professional career is distinguished by her roles in academia and research management. Since 2010, she has served as a Professor at the Faculty of Medicine, Vasile Goldis Western University of Arad (VGWU), where she has made significant contributions to the fields of histology and cell biology. Her expertise in these areas is evidenced by her ongoing research and teaching responsibilities.

In 2016, Prof. Hermenean was appointed Director of the VGWU Doctoral Studies Council, a role in which she has overseen the management and strategic development of doctoral programs in Medicine and Biology. Her leadership extended further in 2017 when she joined the Faculty of Engineering in Foreign Languages at Politehnica University of Bucharest, contributing to the Master Program in Biomaterials for Tissue Engineering. She has taught various courses related to cell and tissue biology, tissue regeneration, and debilitating diseases of tissue.

In 2020, Prof. Hermenean became the Director of the Life Science Institute and Principal Investigator at the Institute of Life Sciences, VGWU. Here, she manages research projects and oversees activities in microscopy labs and the animal facility, reflecting her deep engagement in both research and administration.

Contributions and Research Focus 🔬

Prof. Hermenean’s research contributions are broad and impactful, focusing on several key areas:

  1. Histology and Histopathology: Her work in these fields explores the microscopic structure of tissues and the pathological changes associated with various diseases. This includes significant contributions to understanding how cellular and tissular alterations can affect health.
  2. Phytomedicine: Prof. Hermenean has researched the modulation of signal transduction pathways by phytochemicals, their molecular regulation of anti-inflammatory and anti-fibrotic responses, and their interactions with drugs and chemicals.
  3. Nanobiotechnology: She has been involved in the characterization of bio-interfaces and in vivo biocompatibility studies of nanomaterials. Her work includes assessing the interactions between nanomedicines and biological systems, as well as evaluating structural and ultrastructural toxicological effects.
  4. Regenerative Medicine: Prof. Hermenean’s research also covers tissue repair and regeneration pathways, focusing on molecular signals, growth factors, and the mechanisms of tissue regeneration.

Accolades and Recognition 🏆

Prof. Hermenean’s work has garnered significant recognition within the scientific community. She holds a habilitation in Biology, a postdoctoral qualification that allows her to supervise PhD candidates. Her research has led to numerous publications in peer-reviewed journals, with an H-index of 30 on Scopus and 34 on Google Scholar. Additionally, she has been awarded several patents for her innovations in pharmaceutical compositions and drug delivery systems, underscoring her contributions to practical and applied sciences.

Impact and Influence 🌍

Prof. Hermenean’s influence extends beyond her research and teaching. Her roles in managing research councils and institutes highlight her ability to shape research strategies and educational programs. Her contributions have had a tangible impact on the advancement of biomedical sciences, particularly in the fields of histology, nanobiotechnology, and regenerative medicine.

Her work on phytomedicine and nanobiotechnology is particularly notable for its potential applications in developing new therapeutic approaches and improving existing medical treatments. Her patents and research projects reflect her commitment to translating scientific discoveries into practical solutions.

Legacy and Future Contributions 🔮

Prof. Hermenean’s legacy is marked by her dedication to advancing scientific knowledge and training the next generation of researchers. Her leadership in establishing and managing research infrastructures, such as the animal facility and microscopy labs at VGWU, demonstrates her commitment to fostering a supportive environment for cutting-edge research.

Looking ahead, Prof. Hermenean is poised to continue making significant contributions to her fields of expertise. Her ongoing research and collaborations are expected to yield further advancements in phytomedicine, nanobiotechnology, and regenerative medicine. Her role as a mentor and educator will also play a crucial part in shaping future research and development in these areas.

🎓Publication 

Chrysin-loaded calixarene-cyclodextrin ternary drug delivery system inhibits TGF-β and galectin-1 mediated pathways in diabetic liver

  • Authors   :Balta, C., Herman, H., Ciceu, A., D’Amico, M., Hermenean, A..
  • Journal    :Biochemical Pharmacology
  • Year         :2024

Dexmedetomidine improves the circulatory dysfunction of the glymphatic system induced by sevoflurane through the PI3K/AKT/ΔFosB/AQP4 pathway in young mice

  • Authors   :Wang, S., Yu, X., Cheng, L., Lu, Y., Wu, X..
  • Journal    :Cell Death and Disease
  • Year         :2024

Exploring In Vivo Pulmonary and Splenic Toxicity Profiles of Silicon Quantum Dots in Mice

  • Authors   :Cristian, R.-E., Balta, C., Herman, H., Dinischiotu, A., Stan, M.S..
  • Journal    :Materials.
  • Year         :2024

Ketamine administration causes cognitive impairment by destroying the circulation function of the glymphatic system

Colloidal and Biological Characterization of Dual Drug-Loaded Smart Micellar Systems

  • Authors   :Herman, H., Rata, D.M., Cadinoiu, A.N., Atanase, L.I., Hermenean, A..
  • Journal    :Polymers
  • Year         :2024

Prof. Mohamed Abdelzaher|Pharmacology | Best Researcher Award

Prof. Mohamed Abdelzaher, Pharmacology,Best Researcher Award

Prof. Mohamed Abdelzaher, at Environmental Science and Industrial Development Department, Faculty of Postgraduate Studies for Advanced Sciences, Beni-Suef University,Egypt

PROFILE

scopus

Early Academic Pursuits 🎓

Mohamed Abuelseoud Abdelzaher embarked on his academic journey at Minia University, where he pursued a Bachelor of Science degree at the Faculty of Science. His passion for environmental science led him to further his studies, culminating in an MSc in Environmental Chemistry from the same institution. His master’s thesis focused on the physico-chemical properties of sewage sludge ash blended cement pastes, a topic that underscored his growing interest in sustainable construction materials. His academic pursuits did not stop there, as he later achieved a Ph.D. in Environmental Science and Industrial Development from the Faculty of Postgraduate Studies for Advanced Sciences at Beni-Suef University in 2019. His doctoral research delved into enhancing the physico-mechanical properties of white cement through the application of nanoparticles, highlighting his commitment to advancing materials science and its environmental implications.

Professional Endeavors 🏢

Dr. Abdelzaher’s professional career began in the industrial sector, where he worked as a Quality Control and Labs Manager at Italcementi Group, Helwan Cement Co., from 2005 to 2017. This role allowed him to gain substantial experience in quality assurance and environmental management within the cement industry. His work in this capacity was instrumental in ensuring that the company adhered to stringent environmental and quality standards, contributing to the sustainability of its operations.

In 2017, Dr. Abdelzaher transitioned into academia, taking on the role of Assistant Professor of Environmental Science and Industrial Development at Beni-Suef University’s Faculty of Postgraduate Studies for Advanced Sciences. In this role, he has been actively involved in teaching, research, and mentorship, guiding the next generation of environmental scientists and engineers. His professional journey reflects a seamless blend of industry experience and academic expertise, making him a respected figure in both fields.

Contributions and Research Focus 🔬

Dr. Abdelzaher’s research is primarily centered on the application of nanomaterials in construction materials and environmental science, with a particular emphasis on waste management. His work on enhancing the properties of white cement using nanoparticles is a testament to his innovative approach to solving environmental and industrial challenges. By integrating cutting-edge nanotechnology into traditional construction materials, he has contributed to the development of more durable and sustainable building solutions.

In addition to his research in construction materials, Dr. Abdelzaher has also made significant contributions to environmental science, particularly in the area of waste management. His work explores how waste materials can be repurposed and utilized in environmentally friendly ways, thereby reducing their impact on the environment and contributing to a circular economy.

Accolades and Recognition 🏅

Throughout his career, Dr. Abdelzaher has received numerous accolades and certifications that attest to his expertise and leadership in his field. He is a certified environmental specialist, having received recognition from the Egyptian Ministry of Environment. He also holds an MBA from Ain Shams University, which complements his scientific expertise with strong business acumen.

Dr. Abdelzaher’s leadership skills have been recognized on an international level, as evidenced by his fellowship from the Science Leadership Program in Africa. This fellowship highlights his role as a thought leader in environmental science, particularly in the context of developing nations. Additionally, he has been awarded fellowships for curriculum development and environmental management, further underscoring his contributions to academia and industry alike.

Impact and Influence 🌍

Dr. Abdelzaher’s work has had a profound impact on both the academic community and the industrial sector. His research on nanomaterials and waste management has influenced the development of more sustainable construction practices, contributing to the global push towards greener building solutions. His teachings and mentorship at Beni-Suef University have inspired countless students to pursue careers in environmental science, ensuring that his influence will be felt for generations to come.

Moreover, his involvement in various professional organizations and his role as a reviewer for environmental journals published by Elsevier demonstrate his commitment to advancing the field of environmental science. Through these roles, he has helped shape the direction of research and development in his field, ensuring that it continues to address the most pressing environmental challenges of our time.

Legacy and Future Contributions 🚀

As Dr. Abdelzaher continues his career, his legacy is one of innovation, leadership, and dedication to sustainability. His work in nanotechnology and waste management has laid the groundwork for future advancements in these fields, and his influence as an educator ensures that his knowledge and expertise will be passed on to the next generation of environmental scientists.

🎓Publication 

Effective impact of nano-plastic-waste incorporated with nanotitina on the physical, mechanical and microstructural properties of white cement pastes composites for progressing towards sustainability

  • Authors   :Abdelzaher, M.A., Farghali, A.A., Hamouda, A.S.
  • Journal    :Scientific Reports
  • Year         :2024

Production, characterization and performance of green geopolymer modified with industrial by-products

    • Authors :Abbas, R., Abdelzaher, M.A., Shehata, N., Tantawy, M.A.
    • Journal   :Scientific Report
    • Year       : 2024

Effect of ginger, chamomile, and green tea extracts on prostate cancer cells

Bacterial biodegradation of oil-contaminated soil for pollutant abatement contributing to achieve sustainable development goals: A comprehensive review

  • Authors  :Aziz, Z.S., Jazza, S.H., Dageem, H.N., Balboul, B.A., Abdelzaher, M.A.
  • Journal   :Results in Engineering
  • Year        :   2024

Experimental and Theoretical Study of Water Amount on the Rheological Features of Marble Sludge Grout

Dr. Samer Younes| Pharmacology| Best Researcher Award-1225

Dr. Samer Younes,Pharmacology ,Best Researcher Award

Dr. Samer Younes, at Tartous University, Syria

 Profile

Goole scholar

    

🎓Early Academic Pursuits :

Samer Younes began his academic journey with a strong focus on pharmaceutical sciences. His passion for the field was evident early on as he pursued a Bachelor’s degree in Pharmacy from the Faculty of Pharmacy at Tartous University, Syria. His dedication to his studies was unwavering, and he successfully completed his degree on January 31, 2024. This foundational education equipped him with extensive knowledge in clinical pharmacology and pharmaceutical services, setting the stage for his professional and academic endeavors.

💼Professional Endeavors :

Upon completing his degree, Samer Younes embarked on a professional career that quickly showcased his capabilities and commitment to the field. With two years of experience in pharmaceutical services, he demonstrated a compassionate and systematic approach to his work. His extensive background in clinical pharmacology and strong clinical and technical knowledge enabled him to deliver community health education programs effectively. Samer’s professional journey has been marked by a relentless pursuit of excellence and a desire to contribute significantly to the field of pharmacy.

🧪Contributions and Research Focus :

Samer Younes has made notable contributions to pharmaceutical research and innovation. His research endeavors have been diverse and impactful, with a focus on nutrition, nutrients, and pharmacology. He has completed or is currently engaged in 19 research projects, showcasing his dedication to advancing knowledge in his field. His work has been recognized and cited in relevant academic databases, reflecting the significance of his contributions to the scientific community. Samer’s research is characterized by its rigor and relevance, addressing critical issues in pharmacology and drug discovery.

🏆Accolades and Recognition :

Throughout his academic and professional journey, Samer Younes has received recognition for his outstanding contributions. His research has been published in reputable journals, and he has been involved in 19 consultancy or industry-sponsored projects. These achievements underscore his expertise and the high regard in which he is held within the pharmaceutical community. Although specific awards and honors have not been detailed, his professional and academic accomplishments speak volumes about his impact and influence in the field.

🌍Impact and Influence :

Samer Younes’s work has had a significant impact on both his immediate community and the broader field of pharmaceutical sciences. His involvement in community health education programs has helped raise awareness and improve public health outcomes. Additionally, his research contributions have advanced the understanding of various aspects of pharmacology, influencing both academic and practical applications. His commitment to sharing knowledge and improving healthcare practices highlights his role as a leader and innovator in the field.

🌟Legacy and Future Contributions :

Looking ahead, Samer Younes is poised to make even greater contributions to pharmaceutical sciences. His pursuit of full-funded scholarships for continuing his master’s degree studies indicates a commitment to furthering his education and research capabilities. With his solid academic background, professional experience, and ongoing research projects, Samer is well-positioned to leave a lasting legacy in the field. His future contributions are expected to drive innovation, enhance pharmaceutical practices, and inspire the next generation of pharmacists and researchers.

🎓Publication 

The efficacy of a 24-hour preoperative pause for SGLT2-inhibitors in type II diabetes patients undergoing bariatric surgery to mitigate euglycemic diabetic ketoacidosis

  • Authors   :Samer Younes
  • Journal    :Diabetes Epidemiology and Management
  • Year         : 2024

The role of nutrition on the treatment of Covid 19

    • Authors :Samer Younes
    • Journal   :Human Nutrition & Metabolism
    • Year       : 2024

The role of micronutrients on the treatment of diabetes

  • Authors  :Samer Younes
  • Journal    :Human Nutrition & Metabolism
  • Year         :  2024

The impact of micronutrients on the sense of taste

  • Authors  :Samer Younes
  • Journal   :Human Nutrition & Metabolism
  • Year        :   2023

A Comprehensive Examination of the Nutritional Sufficiency of Vegan Recipes Widely Available in the Market

  • Authors  :Samer Younes
  • Journal   :J. Nutrition and Food Processing
  • Year        :   2024

Prof Dr.Jin Tae Hong, Pharmacology,Pharmaceutical Research Pioneer Award

Prof Dr.Jin Tae Hong ,Pharmacology ,Pharmaceutical Research Pioneer Award

Prof Dr.Jin Tae Hong, at Chungbuk National University, University of Trento,South Korea

Author Profile

 

Education:

  • Ph.D. in Toxicology, University of Kentucky, USA, 1996
    M.S. in Pharmacy, Chungbuk National University, Korea, 1990
    B.S. in Pharmacy, Chungbuk National University, Korea, 1988
    Professional Experience:
  • Chief of Research Board, Korea Research Foundation
    Dean, College of Pharmacy, Chungbuk National University
    President, The Pharmaceutical Society of Korea
    Director, Medical Research Center, Korea
    Director, Innovation Center for Biohealth Industry of Chungbuk Province

Research Interests:

 

  • Microenvironment in tumor development 🧬
    Drug development for Cancer and Neurodegenerative diseases 💊
    Cytokines and development of drugs for inflammatory diseases 🔬
    Awards:
  • Numerous awards including The Best Researcher Award and Excellent Science Paper Award
    Recipient of the Hwalmyeungsoo Pharmacology Award and DB Research Award
    Recent Articles:
  • Author of over 750 articles, with more than 400 as corresponding author

🎓Publication Top Noted:

Paper Title : Modulatory effects of point-mutated IL-32θ (A94V) on tumor progression in triple-negative breast cancer cells

  • Authors Park, H.-M., Park, J.-Y., Kim, N.-Y., … Hong, J.T., Yoon, D.-Y.
  • Journal: BioFactors
  • Year: 2024
Paper Title : Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer
    • Authors : Yu, J.E., Yeo, I.J., Han, S.-B., … Son, D.J., Hong, J.T.
    • Journal:Experimental and Molecular Medicine
    • Year: 2024
Paper Title :Presenilin-2 knock-In mice show severe depressive behavior via DVL3 downregulation
  • Authors: Yoo, S.S., Lee, D.W., Ham, H.J., … Han, S.-B., Hong, J.T.
  • Journal:CNS Neuroscience and Therapeutics
  • Year:2024
Paper Title :Abused drug-induced intracranial self-stimulation is correlated with the alteration of dopamine transporter availability in the medial prefrontal cortex and nucleus accumbens of mice
  • Authors: Zhang, Y.-Q., Min, H.K., Hong, E., … Hong, J.T., Yun, J.
  • Journal:Biomedicine and Pharmacotherapy
  • Year: 2003

Paper Title :(E)-2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol alleviates inflammatory responses in LPS-induced mice liver sepsis through inhibition of STAT3 phosphorylation

  • Authors: Kim, B., Yu, J.E., Yeo, I.J., … Han, S.B., Hong, J.T.
  • Journal: International Immunopharmacology
  • Year: 2003